Home > BIGG > Search result

    Results: 2

    Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

    Dent, S; Brezden-Masley, C; Clarke, B; Davis, MK; Jassal, DS; Johnson, C; Lemieux, J; Paterson, I; Sebag, IA; Simmons, C; Sulpher, J; Thain, K; Thavendiranathan, P; Wentzell, JR; Wurtele, N; Côté, MA; Fine, NM; Haddad, H; Hayley, BD; Hopkins, S; Joy, AA; Rayson, D; Stadnick, E; Straatman, L; Virani, SA.
    Can. j. cardiol; 32 (7), 2016
    Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
    Antineoplastic Agents, Biomarkers, Cardiotonic Agents, Cardiotoxins, Troponin T, Natriuretic Peptide, Brain, C-Reactive Protein, Antineoplastic Agents/adverse effects, Arrhythmias, Cardiac, Cardiotoxicity, Coronary Thrombosis, Early Diagnosis, Echocardiography, Three-Dimensional, Hypertension/therapy, Magnetic Resonance Imaging, Cine, Myocardial Ischemia, Neoplasms/therapy, Primary Prevention, Radiotherapy, Risk Factors, Ventricular Dysfunction, Left, Cardiotoxicity/diagnosis, Cardiotoxins/adverse effects, Radiotherapy/adverse effects
    Fulltext

    Neutropenic sepsis: prevention and management in people with cancer

    England. National Institute for Health and Care Excellence.
    This guideline covers preventing, identifying and managing neutropenic sepsis in children, young people and adults receiving treatment for cancer in the community and in secondary and tertiary care. It aims to reduce the risk of infection in people with neutropenia (low number of white blood cells) who a...
    Antineoplastic Agents/adverse effects, Tertiary Healthcare, Neutropenia/drug therapy, Sepsis/prevention & control, Anti-Bacterial Agents/therapeutic use, Neutropenia/diagnosis
    Fulltext